317 related articles for article (PubMed ID: 15850334)
1. [Surgical treatment of Parkinson's disease].
Maciaczyk J; Swietaszczyk C; Kasprzak HA
Przegl Lek; 2004; 61(12):1383-8. PubMed ID: 15850334
[TBL] [Abstract][Full Text] [Related]
2. Future and current surgical therapies in Parkinson's disease.
Betchen SA; Kaplitt M
Curr Opin Neurol; 2003 Aug; 16(4):487-93. PubMed ID: 12869808
[TBL] [Abstract][Full Text] [Related]
3. Surgical treatment of Parkinson's disease.
Obeso JA; Rodríguez MC; Gorospe A; Guridi J; Alvarez L; Macias R
Baillieres Clin Neurol; 1997 Apr; 6(1):125-45. PubMed ID: 9426872
[TBL] [Abstract][Full Text] [Related]
4. Toward full restoration of synaptic and terminal function of the dopaminergic system in Parkinson's disease by stem cells.
Isacson O; Bjorklund LM; Schumacher JM
Ann Neurol; 2003; 53 Suppl 3():S135-46; discussion S146-8. PubMed ID: 12666105
[TBL] [Abstract][Full Text] [Related]
5. [Surgical treatment of Parkinson's disease as a supplement to pharmacological therapy].
Jabłońska B; Dabek J; Lepich T
Wiad Lek; 2006; 59(11-12):823-8. PubMed ID: 17427499
[TBL] [Abstract][Full Text] [Related]
6. Transplantation of autologous sympathetic neurons as a potential strategy to restore metabolic functions of the damaged nigrostriatal dopamine nerve terminals in Parkinson's disease.
Nakao N; Shintani-Mizushima A; Kakishita K; Itakura T
Brain Res Rev; 2006 Sep; 52(2):244-56. PubMed ID: 16644019
[TBL] [Abstract][Full Text] [Related]
7. Long-term glial cell line-derived neurotrophic factor overexpression in the intact nigrostriatal system in rats leads to a decrease of dopamine and increase of tetrahydrobiopterin production.
Sajadi A; Bauer M; Thöny B; Aebischer P
J Neurochem; 2005 Jun; 93(6):1482-6. PubMed ID: 15935064
[TBL] [Abstract][Full Text] [Related]
8. Impact of grafted serotonin and dopamine neurons on development of L-DOPA-induced dyskinesias in parkinsonian rats is determined by the extent of dopamine neuron degeneration.
Carlsson T; Carta M; Muñoz A; Mattsson B; Winkler C; Kirik D; Björklund A
Brain; 2009 Feb; 132(Pt 2):319-35. PubMed ID: 19039008
[TBL] [Abstract][Full Text] [Related]
9. [Pathophysiological bases, clinical results and indications for surgical treatment in Parkinson disease].
Obeso JA; Linazasoro G; Gorospe A; Rodríguez MC; Guridi J; Ramos E
Neurologia; 1999 May; 14 Suppl 1():54-71. PubMed ID: 10377730
[TBL] [Abstract][Full Text] [Related]
10. The physiological and pharmacological role of basic fibroblast growth factor in the dopaminergic nigrostriatal system.
Grothe C; Timmer M
Brain Res Rev; 2007 Apr; 54(1):80-91. PubMed ID: 17229467
[TBL] [Abstract][Full Text] [Related]
11. Striatal and extrastriatal dopamine in the basal ganglia: an overview of its anatomical organization in normal and Parkinsonian brains.
Smith Y; Villalba R
Mov Disord; 2008; 23 Suppl 3():S534-47. PubMed ID: 18781680
[TBL] [Abstract][Full Text] [Related]
12. Metabolic activity of cerebellar and basal ganglia-thalamic neurons is reduced in parkinsonism.
Rolland AS; Herrero MT; Garcia-Martinez V; Ruberg M; Hirsch EC; François C
Brain; 2007 Jan; 130(Pt 1):265-75. PubMed ID: 17148469
[TBL] [Abstract][Full Text] [Related]
13. [Effects of simultaneous transplant of foetal mesencephalic cells in the striatum and the subthalamic nucleus of hemiparkinsonian rats].
Pavón-Fuentes N; Macías-González R; Blanco-Lezcano L; Alvarez-González L; Martínez-Martí L; Castillo-Díaz L; De La Cuétara Bernal K; Díaz C; Lorigados-Pedre L; Coro Y; García-Varona AY; Rosillo JC; Díaz E
Rev Neurol; 2002 May 16-31; 34(10):917-23. PubMed ID: 12134319
[TBL] [Abstract][Full Text] [Related]
14. Levodopa enhances synaptic plasticity in the substantia nigra pars reticulata of Parkinson's disease patients.
Prescott IA; Dostrovsky JO; Moro E; Hodaie M; Lozano AM; Hutchison WD
Brain; 2009 Feb; 132(Pt 2):309-18. PubMed ID: 19050033
[TBL] [Abstract][Full Text] [Related]
15. Mapping neuronal activity of the basal ganglia in experimental models of Parkinson's disease: contributions of the [14C]2-deoxyglucose method.
Orzi F; Fornai F; Blandini F
Funct Neurol; 2000; 15(4):269-76. PubMed ID: 11213530
[No Abstract] [Full Text] [Related]
16. Transplantation of mouse embryonic stem cell-derived neurons into the striatum, subthalamic nucleus and substantia nigra, and behavioral recovery in hemiparkinsonian rats.
Inden M; Kim DH; Qi M; Kitamura Y; Yanagisawa D; Nishimura K; Tsuchiya D; Takata K; Hayashi K; Taniguchi T; Yoshimoto K; Shimohama S; Sumi S; Inoue K
Neurosci Lett; 2005 Oct; 387(3):151-6. PubMed ID: 16023291
[TBL] [Abstract][Full Text] [Related]
17. Functional organization of the basal ganglia: therapeutic implications for Parkinson's disease.
Obeso JA; Rodríguez-Oroz MC; Benitez-Temino B; Blesa FJ; Guridi J; Marin C; Rodriguez M
Mov Disord; 2008; 23 Suppl 3():S548-59. PubMed ID: 18781672
[TBL] [Abstract][Full Text] [Related]
18. Anatomical and functional reconstruction of the nigrostriatal pathway by intranigral transplants.
Gaillard A; Decressac M; Frappé I; Fernagut PO; Prestoz L; Besnard S; Jaber M
Neurobiol Dis; 2009 Sep; 35(3):477-88. PubMed ID: 19616502
[TBL] [Abstract][Full Text] [Related]
19. Continuous exposure to glial cell line-derived neurotrophic factor to mature dopaminergic transplants impairs the graft's ability to improve spontaneous motor behavior in parkinsonian rats.
Winkler C; Georgievska B; Carlsson T; Lacar B; Kirik D
Neuroscience; 2006 Aug; 141(1):521-31. PubMed ID: 16697115
[TBL] [Abstract][Full Text] [Related]
20. The influence of the subthalamic nucleus upon the damage to the dopamine system following lesions of globus pallidus in rats.
Wright AK; Arbuthnott GW
Eur J Neurosci; 2007 Aug; 26(3):642-8. PubMed ID: 17634067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
